kabutan

StemCell Institute(7096) Summary

7096
TSE Growth
StemCell Institute
780
JPY
-8
(-1.02%)
Dec 12, 3:30 pm JST
5.00
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
24.5
PBR
3.01
Yield
ー%
Margin Trading Ratio
12.69
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
786 JPY 5.05 USD
Previous Close Dec 11
788 JPY 5.04 USD
High Dec 12, 9:13 am
794 JPY 5.10 USD
Low Dec 12, 2:07 pm
780 JPY 5.00 USD
Volume
15,400
Trading Value
0.01B JPY 0.08M USD
VWAP
785.36 JPY 5.04 USD
Minimum Trading Value
78,000 JPY 500 USD
Market Cap
7.99B JPY 0.05B USD
Number of Trades
62
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Mid
1-Year Average
201
1-Year High Jul 16, 2025
5,341
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 46,400 340,200 7.33
Nov 28, 2025 49,100 351,100 7.15
Nov 21, 2025 39,500 343,600 8.70
Nov 14, 2025 28,300 345,500 12.21
Nov 7, 2025 30,700 319,300 10.40
Company Profile
StemCell Institute operates a cell bank business for regenerative medicine, focusing on the separation and storage of umbilical cord blood. It is part of the Nihon Trim Group.
Sector
Services
StemCell Institute develops a cell bank business for regenerative medicine and cell therapy. The company separates and stores cells derived from perinatal tissues such as umbilical cord blood and umbilical cords for future medical treatments. Umbilical cord blood contains hematopoietic stem cells and mesenchymal cells, and clinical research is progressing on regenerative medicine and cell therapy for pediatric central nervous system diseases and autism spectrum disorders. StemCell Institute has cell processing centers in Tokyo and Yokohama, and a cell storage center in Yokohama, with various certifications including a license for manufacturing specific cell products. In addition to umbilical cord blood storage, the company has also launched umbilical cord tissue storage services. StemCell Institute is also engaged in the development of regenerative medicine products and business development and investment in related fields.